Connect Sign In
Nathan Boggs, MD, PhD, an assistant professor of medicine at the Uniformed Services University who is engaged in systemic mastocytosis (SM) translational research, helped Mark Withers, MD, obtain a definitive diagnosis of SM after 20-plus years. Tracy George, MD, ARUP Laboratories president and chief scientific officer, has led the effort to develop highly sensitive tests at ARUP that aid in the diagnosis of SM and has played a key role in clinical trials for emerging treatments. |
January 25, 2023 |
ARUP’s Highly Sensitive Tests Help Solve Diagnostic Puzzles for Patients With… For 20-plus years, Mark Withers had inexplicable episodes of a severe anaphylaxis-like |
Cases of respiratory syncytial virus (RSV), influenza, and COVID-19 in children, older adults, and other vulnerable populations are on the rise and warrant laboratory testing to inform treatment. |
January 19, 2023 |
Increased Respiratory Disease Incidence Warrants Laboratory Testing for Informed… As respiratory viruses cocirculate this season, laboratory testing is increasingly essential |
ARUP Consult®, a free source of laboratory testing information for clinicians, released several new and updated resources in December. |
January 4, 2023 |
ARUP Consult Provides New Resources on Multiple Sclerosis, Minimal Residual Disease, and Mumps… ARUP Consult, a free source of expert guidance in laboratory testing, has released new |
|
December 21, 2022 |
New ARUP Resource Simplifies Laboratory Testing Decisions for Clinicians Treating… A new ARUP Consult tool helps clarify the testing requirements for medication |
ARUP Consult®, a free source of laboratory testing information for clinicians, released several new and updated resources in November. |
December 6, 2022 |
ARUP Consult Updates Resources on Venous Thromboembolism, Cytomegalovirus, and Hemoglobinopathies… ARUP Consult, a free source of expert guidance in laboratory testing, has updated |
The condition of venous thromboembolism, illustrated here, can be treated using direct oral anticoagulants (DOACs) such as direct factor Xa inhibitors. ARUP’s new chromogenic assays can be used to help assess treatment efficacy. |
November 28, 2022 |
New ARUP Tests Measure Levels of Direct Factor Xa Inhibitors to Ensure Quality Patient Care Routine monitoring of patients taking direct factor Xa inhibitors is not required, but the |
ARUP Institute for Research and Innovation in Diagnostic and Precision Medicine™ We accelerate the development and adoption of cutting-edge diagnostic and prognostic technologies advancing patient care through groundbreaking science and engineering. The Sherrie Perkins Research and Innovation Collaboration Grant The Sherrie Perkins Research and Innovation Collaboration Grant funds cutting-edge research in laboratory medicine.
Test Information
